The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

Clinical trial NCT02658838 · UNKNOWN

Trial details

NCT number: NCT02658838
Sponsor: Beijing Anzhen Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

LOVASTATIN/TICAGRELOR [VA Drug Interaction]

Start date: 2015-04-01
Primary completion: 2016-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.